Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Novo Nordisk Invests $1.2B to Establish New Production Facility in Denmark | Contract Pharma

What are you searching for?

Sign in
Breaking News

Novo Nordisk Invests $1.2B to Establish New Production Facility in Denmark

Will feature a finished production facility and warehouse spanning over 40,000 sq m.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Novo Nordisk is investing 8.5 billion Danish kroner ($1.2 billion) to establish a new production facility in Odense, Denmark—marking the first time in this century that Novo Nordisk will break ground in Denmark by establishing a new production site. 
 
The new site will feature a finished production facility and warehouse spanning over 40,000 m2. Designed to be modular and flexible, it will accommodate multiple product types within rare disease.  
 
“The facility will utilize advanced technology and innovative equipment to ensure the highest quality to patients and meet the growing global demand for our life-changing medicines,” says Henrik Wulff, executive vice president, Product Supply, Quality & IT of Novo Nordisk. “We are proud to build on our heritage in Denmark and look forward to embarking on this journey in Odense, a well-connected city with a dynamic community and talented workforce.”
 
The new facility will be established with a commitment to preserve nature in the area, and more than 4,000 new trees will be planted at the site. Buildings will be equipped with solar panels to enhance on-site electricity generation. The landscape will be designed by reusing excess soil, wooden materials and other sustainable resources to create lakes, forests and community spaces open to the public.
 
Construction work has commenced and is scheduled to be completed in 2027. The investment is expected to create 400 permanent jobs upon completion of the facilities. During the construction process, up to 1,000 external employees will be working on-site.

Related News

Earlier this year, Novo Nordisk announced plans to invest $4.1 billion to build a second fill and finishing manufacturing facility in Clayton, North Carolina.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics